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Obesity and hyperlipidaemia in adult males in a Semi-urban community in 
Jordan 




Objective:  To describe the relationship between obesity and hyperlipidaemia. 
Methods: Cluster sampling technique-probability of households from Sareeh area. A total of 400 
apparently healthy adult males aged 30-50 years were invited to participate in the study, of whom 
306 completed the study. 
A pilot tested interview questionnaire was designed in the study to collect  the dietary 
history. Height, weight, waist circumference, triglycerides (TRIG) and total cholesterol (CHOL) 
were measured.  Obesity was categorized into three groups as indicated by BMI-C based on WHO 
(1997) for generalized obesity and for classifications of central obesity using waist circumference 
categories based on (Lean et al, 1995). 
Results: The means of plasma triglycerides and total cholesterol increased significantly with 
increasing levels of waist circumference and BMI categories (P<0.05).  
 There was an increase in the prevalence rates (PRs) of hypertriglyceridaemia and 
hypercholesterolaemia with increasing levels of obesity and its duration. The proportion ratios of 
hypertriglyceridaemia and hypercholesterolaemia for subjects with high and moderate obesity levels 
compared with subjects with normal levels were (10.1-11.6) and (6.7 -8.1) times respectively; 
whereas for subjects with duration of overweight>20 years compared with subjects with duration of 
obesity <10 years ranged (2.11-2.96) times.  Also odds ratios (ORs) of hypertriglyceridaemia and 
hypercholesterolaemia after controlling for confounded factors were increased with increasing 
levels of obesity and its duration, the highest (OR) in high obesity levels ranged (11.59-19.18, 95% 
CI, P<0.001) whereas for duration of obesity >20 years ranged (16.78-20.94, 95% CI, P<0.001). 
Central obesity had a potential risk on hypertriglyceridaemia and hypercholesterolaemia more than 
generalized obesity. 
 Conclusions: amount of body fat, location and duration are the major risk factors on hyper- trigly 
ceridaemia and hypercholesterolaemia which emphasizes the need for concentrated e-ffort  to 
prevent and treat obesity rather than just any associated co-morbidities. 
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 البدانة وفرط الشحميات في الدم عند الذكور البالغين  في مجتمع شبه الحضر في  الأردن
تهدف الدراسة بشكل رئيس إلى معرفة  العلاقة بين السمنة و شذوذ شحميات الدم،  عند الذكور البالغين،  في طريقة الدراسة:  
عاما ًوبدوأ اصحاء. واعتمدت منطقة الصريح حالةً دراسية،ً  05-03ارهم من مجتمع شبه الحضر في  الأردن الذين تراوحت أعم
فرد. وكان  004واستخدمت طريقة العينة العشوائية العنقودية في اختيار بيوت السكان المحليين، بسحب أفراد العينة البالغ عددهم 
) أفراد بدوا 603( %5.67خطوات الدراسة كافةً   معدل الاستجابة النهائي للأفراد المطابقين لشروط الدراسة الذين  أكملوا
المعتمد من قبل منظمة  )C-IMB(أصحاء، وبنسب أعداد متقاربة  للمواقع كلها،  ولتصنيفات  مؤشر الكتلة الجسمية الرئيسة
. كما  2/مكغم 03  ، بدانة  99.92-52، زيادة وزن  52لتصنيف السمنة المتعممة (وزن طبيعي أقل من 7991الصحة العالمية 
 ).5991استخدم  لتصنيف السمنة المركزية محيط الخصر المعتمد من قبل  الباحث لين ورفاقه" (
وقد استخدم لهذه الغاية مقابلة  واستبيان شامل،  صمم لجمع التاريخ الغذائي ، والوزن، والطول،  ومحيط الخصر. 
 ). LOHCيسترول () ،وإجمالي الكولGIRTوشحميات الدم ومنها: الدهون الثلاثية (
بين  50.0 >) اظهر فروقات طردية  عند مستوى حدث LOHC,GIRTأظهرت  أن المعدل الحسابي(النتائج : 
 مستويات  السمنة باستخدام مؤشر كل من الكتلة الجسمية ومحيط الخصر مع زيادة رتبة نمط السمنة.
وى كل من رتبتها،  ومدتها،   حيث تبين أن  نسب  معـدل  كما أظهرت الدراسة أن معدل انتشار شذوذهما  يزداد  مع زيادة مست
- 1.6) ضعـف،  وان المستــوى  المعتـدل للسمنة  تراوح مابين (6.11– 1.01الانتشار   للنمـط  العالي للسمنة تراوحت مابين  (
سنة إذا ما  02 لمـدة السمنـة   ) ضعـف إذا ما قورنا بالمستـوى الطبيعـي(غير البدناء). بينما كان معدل انتشار شذوذهما 6.8
 ضعف.  )11.2-69.2(سنة بالمستـوى  يتراوح مابين 01 >قورنت بمدة السمنة 
)  لمؤشرات السمنة، ومدتها  بعد السيطرة على عوامل بيولوجية، وبيئية ROوتوصلت الدراسة إلى أن عامل الخطر  (
ل من رتبتها،  ومدتها. حيث كان يتراوح    لذوي النمط العالي ) يزداد  مع زيادة مستوى كLOHC,GIRTمختارة   على شذوذ (
ومستوى حدث    %59) عند مستوى ثقة 49.02-87.61سنه مابين( 02 ) ،ولمدة السمنة 81.91-95.11)للسمنة مابين 
 ).LOHC,GIRT. ووجدت الدراسة أن تأثير السمنة المركزية اكثر حدة من السمنة المتعممة  في  شذوذ (100.0>
). وهذا يؤكد LOHC,GIRTالخلاصة: وخلصت الدراسة إلى أن كمية دهن الجسم، وموقعه، ومدته هي متنبئات رئيسة لشذوذ(
 ضرورة تركيز الجهود للوقاية من السمنة ومعالجتها  وليس  لمعالجة الأمراض المتعلقة بها فقط.
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Introduction. Obesity is a widespread metabolic abnormality. It is a growing epidemic 
worldwide including Jordan and has affected people with different ethnic and cultural 
backgrounds1,2,3. Currently, nearly one quarter of the US population is considered to be overweight 
(defined as BMI=25-29.9 kg/ m2), and an additional one quarter is clinically obese, (defined as BMI 
30 kg/ m2) 1.  
Obesity can be defined as a disease of extensive fat accumulation to the extent that health 
and wellbeing are affected. However, the degree of excess fat, its distribution within the body, 
duration and the associated health consequences vary considerably between obese individuals2. 
Obesity has long been recognized as an associated factor with a variety of adverse health 
consequences chiefly among which are diabetes4,5,  hypertension6,7, dyslipidaemia8,9,10, increased 
cardiovascular events and mortality11, and hyperuricaemia12 . These patients are also more likely to 
present with silent disease14,15 and as a cluster of metabolic syndrome2,16. The most commonly 
recognized risk factors in the metabolic syndrome are highly correlated with each other17 and are 
pre-sumed to reflect common metabolic pathways and they interact to increase risk in a synergistic 
fashion18.  
Furthermore, several epidemiological studies showed a positive association between obesity 
and hyperlipidemia19,20. Increases in plasma lipoproteins concentration showed positive association 
with body mass index (BMI), waist circumference, and waist to hip ratio (WHR) 21,22,23. The risk 
was increased among men who had been overweight in adolescence 24. It has been suggested that 
other factors, such as dietary fat from animal source, genetic susceptibility, sedentary life style and 
age, may also play a role in producing hyperlipidemia25, 26,27,28,29,30,31,32,33,34. It seems from the above 
that several ethnic groups are more prone to the development of obesity and its complications. 
Furthermore, a change from the traditional to affluent sedentary life style and accompanying diet 
availability, low price of fat-rich energy-dense diet, and reduced activity from unemployment might 
be considered as main causes of obesity or/and may facilitate expression of genetic predisposition 
of obesity and related diseases35. Also36 and 37 reported that weight reduction could reverse the 
abnormal biochemical characteristics of obesity. Most Clinical studies assessing the health effect of 
peripheral obesity rely on BMI,38 whereas central obesity is determined by waist circumference and 
waist to hip circumference ratio22,39,23 .   
Recent studies conducted in Jordan indicate high prevalence of diabetes mellitus, 
hypertension and hyperlipolipidemia6,40 ,41 ,42. Also cardiovascular diseases are the first leading 
cause of death in Jordan as reported by annual reports of Royal medical services43, (RMS, 2001). 
Data are needed regarding the relationship between obesity and hyperlipidemia in Jordan. It is 
important that factors inducing hyperlipidemia should be addressed in any coordinated strategy to 
tackle the problem of hyperlipidemia and associated co-mobidities. 
 
MATERIALS AND METHODS.Cluster sampling technique-probability of households from 
Sareeh area in the northern of Jordan was used to recruit the studied sample .A total of over three 
hundred of apparently healthy adult males aged 30-50 years were actually included in the study 
which was conducted in 2001. The sample was categorized into approximately equal three groups, 
normal body weight, overweight and obese as indicated by BMIs: < 25, 25-29.99 and 30 kg /m² 
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respectively. Also central obesity was categorized in three groups as indicated by waist 
circumference: normal< 94 cm; moderate > 94- 102; high > 102 cm based on waist circumference 
classifications44.  
A modifiable and pilot tested interview questionnaire was designed in the study to collect 
demographic, socio-cultural, dietary and physical activity factors, current smoking, history of 
weight and disease for participants and their parents, in addition to blood lipids triglycerides (TRIG) 
and cholesterol (CHOL),  
 Anthropometric measurements were performed using the Anthropometric 
Standardization Reference Manual45 . Laboratory measurements were performed using standard 
automated procedures (Hitachi 911) with commercially available kits (Randox manual procedures 
edition 111, 1990 or Roche Diagnostics, 2000). Hypertriglyceridaemia is defined as serum 
triglycerides level of  200 mg/dl whereas elevated plasma cholesterol defined as plasma 
cholesterol level of  200 mg/dl for men aged < 40 years,  240 mg/dl for men aged  40 years. An 
informed consent was obtained from each subject. The study was approved by the Research Ethics 
Committee of Philadelphia University- Jordan. 
   
Data management and analysis.The data was entered into a computer using the SPSS 
(statistical Package for Social Sciences, Windows version 8x, 1997; SPSS Inc, Chicago, 1L, USA. 
Frequency and range checks were performed initially to detect errors in data entry. Detected errors 
were corrected by rechecking the original data formed. 
The prevalence of hypertriglyceridaemia and hypercholesterolaemia and comparing 
proportions in the study sample among population subgroups based on overall and central obesity 
index categories were analyzed using X2 test. Analysis of variance (ANOVA) was performed to test 
significance for mean values of variables between overall and central obesity categories.  
Logistic regression analysis was carried out to estimate risk or odds ratios (ORs) of obesity 
indices, obesity duration categories, selected biological and environmental factors on 
hypertriglyceridaemia and hypercholesterolaemia. Hypertriglyceridaemia and 
hypercholesterolaemia were subdivided into binary variables (normal and abnormal values) and 
used as a dependent variable, whereas obesity indices, duration of obesity categories and selected 
biological and environmental factors were used as independent variables. A P value of < 0.05 was 
used as the criterion of statistical significance. 
 
 
Results. The mean of plasma triglycerides and total cholesterol increased with increasing BMI and 
waist circumference categories and showed significant mean differences among BMI-C and W-C 
(P<0.05) as shown in Table (1a,b).  
Table 2a,b shows prevalence rates and ratios of the proportion of subjects with 
hypertriglyceridaemia and hypercholesterolaemia among obesity categories increased as (BMI-C 
and W-C) increased. 
The results shown in Table (2a,b) indicate that all the absolute proportions of hypertriglyceridaemia 
and hypercholesterolaemia increased as obesity levels increased. Prevalence rates of 
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hypertriglyceridaemia and hypercholesterolae-mia among subjects with high level of central obesity 
or obese category were more than ten times in comparison with subjects with low level of central 
obesity level or non-obese category, whereas for subjects with moderate level of central obesity or 
overweight category were above six times for hypertriglyceridaemia and above eight for 
hypercholesterolaemia in comparison with subjects with low level of central obesity or non-obese 
category. 
 
 Table 1a Descriptive and comparative data for plasma triglycerides and    
   total cholesterol. The study sample classified into non-obese, overweight  













Age/years 0 103 38.60 6.31 0 1 -0.23 0.91 0.969 
 1 100 38.83 6.63 2 0 0.90 0.90 0.612 
 2 103 39.49 6.50 2 1 0.67 0.91 0.764 
TRIG 0 103 126.41 59.01 0 1 -52.61 11.40 0.000 
 1 100 179.02 84.81 2 0 84.24 11.32 0.000 
 2 103 210.65 95.58 2 1 31.63 11.40 0.022 
CHOL 0 103 179.80 29.75 0 1 -33.71 5.71 0.000 
 1 100 213.51 45.02 2 0 52.50 5.66 0.000 
 2 103 232.29 45.36 2 1 18.78 5.71 0.005 
* Results of one-way ANOVA and Scheffe post hook analysis 
             (0) non-obese, (1) overweight, (2) obese 
 
 
Table (3) shows adjusted odds ratio (OR) of hypertriglyceridaemia of obesity categories after 
controlling for age, weight history, parental (CVD, and hypertension), current smoking, physical 
activity and percentage of calorie from fat in the study sample 
The adjusted risk of hypertriglyceridaemia among subjects with moderate central obesity or 
overweight, and high central obesity or obese levels compared with subjects with low level of 
central obesity categories or non-obese were (ORs 5.08-6.27, 95%CI) and (ORs11.59 -13.8, 
95%CI) respectively.  
Parental cardiovascular disease (CVD), age, percentage of calories from dietary fat (%CDF), 
childhood and adolescence obesity were associated significantly with hypertriglyceridaemia 




Table 1b Descriptive Characteristics (Mean+SD) and Multiple Comparisons plasma 
hypertriglyceridaemia and hypercholesterolaemia level using waist circumference categories (W-C) 
for Study Population 
 














TRIG 0 103 126.37 59.01 0 1 -54.24 11.22 0.000 
 1 107 180.61 85.60 2 0 84.86 11.53 0.000 
 2 96 211.23 95.70 2 1 30.62 11.43 0.000 
CHOL 0 103 179.81 29.75 0 1 -32.59 5.57 0.000 
 1 107 212.39 45.03 2 0 55.09 5.72 0.000 
 2 96 234.90 44.48 2 1 22.50 5.67 0.000 
* Results of one-way ANOVA and Scheffe post hook analysis 





Table 2a: Prevalence rate and ratios proportions of subjects with biochemical abnormalities among 
body mass index categories (BMI-C) in the study sample 
 
Indicators 
Overall obesity index 









N. % N. % 
 
N. % 
103 33.7 100 32.6 103 33.7 
TRIG  5 4.9 30 30.0 6.2 52 50.5 10.4 
CHOL  5 4.9 43 43.0 8.9 53 51.5 10.6 
 
 
Table 2b: Prevalence rate and ratios proportions of subjects with hypertriglyceridaemia and 
hypercholesterolaemia among waist circumference categories (W-C) in the study sample 
 
Waist circumference (W-C) 
Indicator Low  Moderate R High  R 
N. % N. % N. % 
103 33.6 107 35.0  96 31.4  
TRIG 5 4.9 35 32.7 6.7 47 49.0 10.1 
CHOL 5 4.9 42 39.3 8.1 54 56.0 11.6 
All (R): calculated with each category by dividing the proportions of biochemical abnormalities 
overweight or moderate or high or obese level / low-level proportion or non-obese proportion. 
All ratios of proportions were significantly larger than 1.00 at P<0.5 based on Chi-square  
statistic. 
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Table (4)shows significance of adjusted risk (ORs)of high plasma   cholesterol for 
participants with moderate level and high levelcentral obesity in comparison with low 
level of central obesity were (10.9, 95%CI) and (19.18, 95%CI) respectively. Whereas 
odds ratios of high plasma cholesterol for overweight and obese subjects in comparison 
with non-obese subject were (6.5, 95%CI) and (14.03, 95%CI), respectively. Central 
obesity categories had a higher (ORs) than overall obesity categories. 
Results shown in Table (5) indicate that the prevalence rates of 
hypertriglyceridaemia and hypercholesterolaemia increase with increasing duration of 
overweight ((BMI > 25 kg/m2). The prevalence rate (PR) of hypertriglyceridaemia 
among subjects with duration two and subjects with duration three, in comparison with 
the reference group, the subjects with duration one; were (1.82; 2.69) 
fold,respectively.Whereas the prevalence rate of hyperchole- sterolaemia among subjects 
with duration two and subjects with duration three in comparison with the reference 
group subjects with duration one were (1.94; 2.11) fold, respectively. 
 
 
Table 3: Adjusted odds ratio (ORs) of hypertriglyceridaemia of obesity categories after controlling 
for age, weight history, cardiovascular disease( CVD), and hypertension among parents, current 
smoking, physical activity and percentage of calorie from dietary fat in the study sample 
 
 
  95% CI for Exp (B)  
Variable Exp (B) Lower Upper P 
Body mass index categories(BMI) 
Parental (CVD) 22.11 1.16 3.82 0.0145 
Childhood obesity 0.29 0.10 0.88 0.0 283 
Adolescence obesity 1.82 0.76 4.36 0.0401 
 %CDF (3) 2.71 1.20 6.12 0.0168 
BMI-C (1) 5.08 1.79 14.43 0.0023 
BMI-C (2) 13.18 4.57 19.5 0.0000 
Waist circumference categories(W-C) 
Parental (CVD)  2.13 1.18 3.84 0.117 
Childhood obesity 0.28 0.09 0.84 0.0229 
Adolescence obesity 2.06 0.88 4.81 0.0958 
%CDF(3) 2.79 1.24 6.27 0.0134 
W-C (1) 6.27 2.25 17.48 0.0004 
W-C (2) 11.59 3.94 34.07 0.0000 
* Each obesity indicator entered separately with controlling factors*%CDF-C(3) = % of calorie 
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The results shown in Table (6) indicate that duration of overweight had a risk on 
hypertriglyceridaemia and hypercholesterolaemia, which increased, steeply in duration 1 and 
sharply in duration two and three. Also, the results showed that the risk of hypercholesterolaemia 
increased steeply with small difference between duration two and three. Also, the results showed 
that the risk of hypertriglyceridaemia increased sharply between duration two and three. 
 
 
Table 4: Adjusted odds ratio (ORs) of hypercholesterolaemia of obesity categories after controlling 
for age, weight history, CVD, and hypertension among parents, current smoking, physical activity 
and percentage of calorie from dietary fat in the study sample 
 
  95% CI for Exp. (B)  
Variable Exp. (B) Lower Upper P 
Body mass index categories(BMI) 
Childhood obesity 2.00 0.90 4.40 0.0870 
%CDF-C(3) 1.89 0.92 3.89 0.0823 
BMI-C (1) 12.6.5 4.62 34.59 0.0000 
BMI-C (2) 14.03 5.03 39.10 0.0000 
Waist circumference categories(W-C) 
%CDF-C(3) 1.71 0.83 3.51 0.1471 
W-C (1) 10.90 4.01 29.59 0.0000 
W-C (2) 19.18 6.87 53.60 0.0000 
* Each obesity indicator entered separately with controlling factors *%CDF-C(3) = % of calorie 
from dietary fat>  34.5 
 
 
Table 5: Prevalence rates and ratios proportions of the subjects with hypertriglyceridaemia and 
hypercholesterolaemia among duration of overweight (BMI> 25 kg/m2) in the study sample 
 
Indicator 
Duration1 Duration2 R Duration3 R 
N % N % N % 
49 16.0 70 23.0 84 27.0 
TRIG- C(1)    10 20.4 26 37.1 1.82 46 54.8 2.69 
CHOL- C(1) 13 26.5 36 51.4 1.94 47 56.0 2.11 
* Ratios were significant in all categories 
*All (R): calculated with each categories by dividing the proportions of 
hypertriglyceridaemia and hypercholesterolaemia in duration 2 or duration 3 / duration 1 
proportion. 
*All ratios of proportions were significantly larger than 1.00 at P<0.5 based on Chi-square statistic. 
*Duration of obesity 1= <10 yrs; 2 = 10-20; 3= >20 
 
Table 6: Adjusted odds ratios (ORs) of duration of overweight (BMI > 25kg/m2) on 
hypertriglyceridaemia and hypercholesterolaemia after controlling for age, weight history, CVD, 
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and hypertension among parents, current smoking, physical activity and percentage of calories from 
dietary fat in the study sample 
 
Hypertriglyceridaemia (TRIG- C(1)) 
95% CI for Exp (B) 
Variable  Exp (B)  Lower  Upper P 
parental (CVD)  1.7466  0.9619 3.1715  0.0669 
%CDF-C(3)  2.9661 1.3216 6.6572 0.0084 
Duration (1)  3.3650  1.0359  10.9314 0.0435 
Duration (2)  8.5595  2.9702  24.6667 0.0001 
Duration (3)  16.7750  5.7349  49.0683 0.0000 
Hypercholesterolaemia( CHOL- C(1)) 
Age-C (2)  0.5208  0.2886  .9399  0.0303 
%CDF-C(3) 1.7996  0.8602 3.7651  0.0303 
Duration (1)  4.7569 1.5264  14.8248 0.0072 
Duration (2)  18.0647 6.34876.5531  51.4020 0.0000 
Duration (3)  20.9417 7.2924  60.138 0.0000 




 These results revealed that a relative risk for hypertriglyceridaemia and 
hypercholesterolaemia is dangerous in participants with duration of overweight more than 10 years. 
Also, parental CVD and subjects whose caloric intake from dietary fat was 34.5%(%CDF-C(3)) 
showed significant relative risk on hypertriglyceridaemia. Also, subjects whose caloric intake from 




Obesity and hypertriglyceridaemia 
In this study the relationship between overall obesity and central obesity with 
hypertriglyceridaemia was investigated using different statistical tests. As shown in Table (1a,b), 
the mean difference of plasma triglycerides when comparing obese with non-obese was 84.1 mg/dl 
and between non-obese with overweight was 52.61 mg/dl, also, between obese and overweight was 
31.63 mg/dl. These results are in agreement with the results revealed by46 who reported that, the 
difference in triglycerides ranged from (62-118) mg/dl between obese and lean. Also, the mean of 
plasma triglycerides for obese and high level of central obesity categories was above the 
recommendations by American Heart Association (AHA) to keep triglycerides below 200 mg/dl as 
reported by47,48 .  
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      Furthermore, Table (2ab) shows that the prevalence rates increased as obesity categories 
increased. Prevalence rate of hypertriglyceridaemia among subjects with obese or high level central 
obesity categories was 10 times than those subjects with non-obese or low level of central obesity 
categories. Also prevalence rate of high plasma triglycerides among subjects with overweight and 
moderate level of central obesity categories was 5.6 times than those subjects with non-obese or low 
level of central obesity categories. These results are in agreement with the results of a study 
conducted in Jordan on a community based survey of a sample of 2152 persons aged 25 years or 
more selected from three locations in Jordan. The results indicate that obese subjects had a higher 
rate of hypertriglyceridaemia (27.1%) compared to that of non-obese subjects, despite some 
differences in the two populations. Furthermore, hypertriglyceridaemia has been associated with 
obesity in several national studies 46,49,50,51. 
 Furthermore, the study findings showed central obesity and overall obesity in relation to 
plasma elevated plasma triglycerides were the dominant risk factors on elevated triglycerides after 
controlling for selected biological and environmental factors as shown in Table (3,4). Adjusted risk 
of hypertriglyceridaemia for overweight or moderate level of central obesity and obesity or high 
level of central obesity compared with low central obesity level or non-obese ranged (OR 5.08-6.27, 
95% CI) and (ORs11.33-13.97, 95% CI) respectively. It is concluded that obesity is associated 
significantly and independently with hypertriglyceridaemia, in agreement with the findings of 
several studies52, 53,37,23,54,55. This result may be considered as indirect evidence that two basic 
mechanisms exist for hypertriglyceridaemia of obesity, overproduction of very low-density 
lipoprotein (VLDL) and defective lipolysis of the triglycerides (TG) rich lipoprotein56.  
 One of the important findings in this study indicate that other factors such as %CDF>34.5 is 
associated significantly and independently with hypertriglyceridaemia compared with subjects 
whose %CDF  33, with significant adjusted (OR) (2.0-3.5; 95% CI). This result is in agreement 
with several studies57,58,59. 
 Furthermore, hypertriglyceridaemia was associated significantly with subjects who reported 
childhood obesity, adjusted relative risk was about 29% higher than those subjects who did not 
report obesity during childhood. Also subjects who had reported adolescence obesity in comparison 
with subjects who had not had relative risk of hypertriglyceridaemia (OR 2.0, 95% CI), as have 
been reported 60,61,62,24. The results of relative risk of childhood and adolescence obesity on 
hypertriglyceridaemia may explain indirectly the changes in body fat distribution that occur at 
adolescent fatness on adult morbidity. Visceral fat occupies approximately 50% of the cross-section 
of visceral fat area in 11-13 years old children63. Between adolescence and childhood the cross-
sectional visceral fat area increases four to five fold 23or may be due to other mechanisms including 
genetic factors that entrain both body fatness and adult morbidity 64   . 
 Parental CVD was associated significantly and positively with hypertriglyceridaemia 
(P<0.05). This result indirectly may indicate role of genetic factors32,65.  
The study results revealed the potential risk of overall and central obesity on 
hypertriglyceridaemia. Furthermore, potential risk of hypertriglyceridaemia was higher 
among subjects with moderate levels of central obesity compared with overweight subjects, 
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while high level of central obesity and obese subjects revealed approximately the same 
magnitude of relative risk. It is concluded that obesity is the dominant risk factor on 
hypertriglyceridaemia, whereas central obesity had a potential effect on 
hypertriglyceridaemia more than overall obesity.  
Obesity and high plasma total cholesterol 
 All statistical investigations performed in this study revealed that the mean level of plasma 
cholesterol increased according to BMI categories and central obesity categories. The mean 
difference between obese or high level of central obesity compared with non-obese or low level of 
central obesity was (52.0 – 55.0) mg/dl as shown in Table (1 a, b) 
 Comparison of the current study findings with those from other Arab countries is hampered 
by the different methods used. The mean values of plasma cholesterol among overweight and obese 
participants were higher than that reported by 66in central Saudi Arabia but the two populations 
were totally different. 67reported that the mean cholesterol level of men from Western Saudi Arabia 
was (183.0) mg/dl. In Jordan the mean cholesterol level of men was (203) mg/dl 41. Han et al; 1995 
conducted a study on a random sample of 2183 men and 2698 women, 20-59 years old from 
Netherlands. The mean cholesterol level for men with waist circumference less than 94 cm was 
201.6 mg/dl and for men with waist circumference 94-<102 cm was 222.7 mg/dl and for men with 
waist circumference more than 102 cm 229.3 mg/dl. In the present study we observed higher values 
of cholesterol for overweight or moderate level of central obesity (212.34) and for obese and high 
level of central obesity (232.29 -234.9) mg/dl. Explanation for the high level of plasma cholesterol 
in the study population may be because food consumption, life style and genetic factors could be of 
minor role while obesity was largely responsible for our findings. 
 Furthermore, investigations in this study indicate that the prevalence rates of high plasma 
cholesterol increased with increasing BMI categories and central obesity categories as shown in 
Tables (2a, b). The prevalence rates (PRs) of hypercholesterolaemia level were 10 times among 
subjects with obesity or high level of central obesity and 8 times in subjects with moderate level of 
central obesity or overweight compared with non-obese or low level of central obesity respectively. 
These results are in agreement with several studies which indicate that high level of cholesterol 
increased as body weight increased 21and confirmed with the NHANES III on 16884 adults, 25 
years and older68 and as has been found by 41. But the magnitude of the prevalence rate was higher 
among our study population. 
 The current study findings as shown in Table (4) indicate that risk of hypercholesterolaemia 
for subjects with overweight or moderate level of central obesity level and subjects with obese 
category or high level of central obesity, in comparison with the reference group non-obese or low 
level of central obesity categories, had significant relative risk (OR 6.12, 95% CI) and (OR >10.0, 
95% CI) respectively. Furthermore, estimated adjusted relative risk (ORs) for the following factors; 
comparing: smoking with non smoking, subjects aged 40-50years with 30-40 years old, %CDF 
34.5 with  33.0%, childhood obesity, history of coronary heart diseasess were independently and 
significantly associated with high level of plasma cholesterol, and had significant adjusted relative 
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risk (OR) on high plasma cholesterol ranging from (1.72-3.93, 95% CI). Our findings in the current 
study are in agreement with several studies 41,58,59,22,34.    
 Relationship of duration of obesity with hypertriglyceridaemia and hypercholesterolaemia 
 Obesity with both its magnitude and location is the most powerful risk factor on 
hypertriglyceridaemia and hypercholesterolaemia shown in the study results. The current findings 
of this study shown in Table (5) indicate that prevalence rates of hypertriglyceridaemia and 
hypercholesterolaemia increased significantly as duration of obesity (BMI> 25kg/ m2) increased. 
Furthermore, obese subjects with duration of obesity  20 years had the highest prevalence rates of 
hypertriglyceridaemia and hypercholesterolaemia. Furthermore, our findings indicate that duration 
of obesity is the dominant independent risk factor on hypertriglyceridaemia and 
hypercholesterolaemia Table (6). The scarcity of such data and the different methods of 
presentation hamper comparison of our data with those from Arab countries or worldwide. Obesity 
may exert its effects only after a long follow-up period. Duration of obesity may reflect the time it 
takes for the metabolic and other effects of obesity to have their full impact. In addition to that the 
age of the subjects was 30-50 years, so obese subjects who had reported long duration revealed that 
the onset of obesity may be in childhood or adolescence or early adulthood. Indirectly several 
studies findings support our data.61 concluded from his study on 508 lean and overweight 
adolescents 13 to 18 years old who participated in the Harvard Growth study of 1922-1935 
overweight in adolescence predicted a broad range of adverse health effects that were independent 
of adult weight after 55 years of follow-up. Also, 24reported that from cross-sectional survey as a 
part of the Bogalusa heart study of cardiovascular risk in 1176 individuals (62% female, 44%) aged 
5 through 17 years at baseline were followed-up for 8 years. That plasma lipid and lipoprotein level, 
blood pressure and plasma insulin all followed-up from childhood into your adulthood with obesity 
at base line, become a significant predictor of adult values. Also 69,70reported that, dyslipidemia, 
hypertension and insulin resistance is frequently present in obese children. The current data of this 
study emphasize that obesity may generate its associated risk factors at a subsequent time. Obesity 
that develops at an early age in adults and is sustained effect on life long is different from the effect 
of obesity that develops in middle age71. Findings from the Manitoba,72 study, along with findings 
from the analysis from the Framingham using study73 suggest that the duration of being obese has 
an important bearing on the putative relationship of body weight and longevity. Data from the 
Framingham Heart study were analyzed using a longer time interval between measurement of 
obesity and subsequent outcome show that obesity clearly, was a significant predictor for 
cardiovascular disease, independent of age, cholesterol level, systolic blood pressure, cigarette 
smoking, left ventricular hypertrophy and glucose intolerance. Furthermore, associations between 
body mass indices and CVD became apparent only after 16 73 or 8 to 14 74years follow-up.  
 Duration of obesity when taken into account will lead to reduction of many discrepancies 
between studies of populations with different ages. Different initial health status and different 
follow-up can be resolved. Furthermore, in short term studies, duration of obesity should be taken 
into account. A number of adverse health effects that occur in adulthood are associated with long 
duration of obesity. Because body mass index appears to be programmed early in life, the 
Gezira Journal Of Health Sciences 2003 vol.1(1) 
 
Gezira Journal Of Health Sciences 2003 vol.1(1)  
 
prevention of overweight in childhood, adolescence and early adulthood may be the most effective 
means of decreasing the associated co-morbidities in middle and late adulthood. 
 
 
 Conclusions. Results of the study indicate that amount of body fat, its location and duration are the 
dominant risk factors on hypertrigly- ceridaemia and hypercholesterolemia, which emphasizes that 
prevention and treatment of obesity may be the most effective means of decreasing 
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